Date Filed | Type | Description |
05/30/2023 |
4
| McHutchison John G (Director) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.
Txns:
| Granted 20,000 options to buy
@ $0.972, valued at
$19.4k
|
|
05/24/2023 |
4
| McHutchison John G (Director) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.
Txns:
| Granted 117,500 shares
@ $0 Sold 25,972 shares
@ $1.0403, valued at
$27k
|
|
05/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/31/2023 |
4
| McHutchison John G (Director) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.
Txns:
| Sold 14,883 shares
@ $0.8232, valued at
$12.3k
|
|
09/06/2022 |
4
| McHutchison John G (Director) has filed a Form 4 on Metacrine, Inc.
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/31/2022 |
4
| McHutchison John G (CEO and President) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.
Txns:
| Granted 83,750 shares
@ $0 Sold 4,614 shares
@ $2.1674, valued at
$10k
Granted 335,000 options to buy
@ $2.3, valued at
$770.5k
Granted 83,750 options to buy
@ $0 |
|
08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/25/2021 |
4
| McHutchison John G (Director) has filed a Form 4 on Metacrine, Inc.
Txns:
| Granted 16,500 options to buy
@ $4.07, valued at
$67.2k
|
|
04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/15/2020 |
3
| McHutchison John G (Director) has filed a Form 3 on Metacrine, Inc. |
08/10/2020 |
4
| McHutchison John G (CEO and President) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.
Txns:
| Sold 11,395 shares
@ $21.7558, valued at
$247.9k
Sold 756 shares
@ $22.4995, valued at
$17k
|
|
03/31/2020 |
4
| McHutchison John G (CEO and President) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.
Txns:
| Granted 50,000 shares
@ $0 Granted 100,000 options to buy
@ $14.45, valued at
$1.4M
|
|
10/01/2019 |
4
| McHutchison John G (CEO and President) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.
Txns:
| Granted 25,000 options to buy
@ $0 |
|
08/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/08/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/08/2019 |
4
| McHutchison John G (Chief Scientific Off/HeadR&D) has filed a Form 4 on GILEAD SCIENCES INC
Txns:
| Granted 8,323 shares
@ $0 Granted 7,104 shares
@ $0 Paid exercise price by delivering 4,453 shares
@ $68.75, valued at
$306.1k
Granted 67,310 options to buy
@ $68.75, valued at
$4.6M
Granted 14,550 restricted stock units
@ $0 |
|
12/19/2018 |
4
| McHutchison John G (Chief Scientific Off/HeadR&D) has filed a Form 4 on GILEAD SCIENCES INC
Txns:
| Granted 6,135 shares
@ $0 Paid exercise price by delivering 2,988 shares
@ $65.12, valued at
$194.6k
|
|
11/13/2018 |
4
| McHutchison John G (Chief Scientific Off/HeadR&D) has filed a Form 4 on GILEAD SCIENCES INC
Txns:
| Paid exercise price by delivering 664 shares
@ $71.18, valued at
$47.3k
Exercised 1,465 restricted stock units
@ $0 |
|
05/10/2018 |
4
| McHutchison John G (Chief Scientific Off/HeadR&D) has filed a Form 4 on GILEAD SCIENCES INC
Txns:
| Granted 79,710 options to buy
@ $65.22, valued at
$5.2M
|
|
04/27/2018 |
3
| McHutchison John G (Chief Scientific Off/HeadR&D) has filed a Form 3 on GILEAD SCIENCES INC |